These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28687736)
21. BRAF V600E Gene Mutation Is Associated With Bilateral Malignancy of Papillary Thyroid Cancer. Liu Z; Lv T; Xie C; Di Z Am J Med Sci; 2018 Aug; 356(2):130-134. PubMed ID: 30219154 [TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278 [TBL] [Abstract][Full Text] [Related]
23. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma]. Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653 [No Abstract] [Full Text] [Related]
24. Effects of BRAF(V600E) mutation on Na(+)/I(-) symporter expression in papillary thyroid carcinoma. Dong H; Shen WZ; Yan YJ; Yi JL; Zhang L J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):77-81. PubMed ID: 26838744 [TBL] [Abstract][Full Text] [Related]
25. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Liu Y; Lv H; Zhang S; Shi B; Sun Y Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817 [TBL] [Abstract][Full Text] [Related]
26. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma. Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630 [TBL] [Abstract][Full Text] [Related]
27. Associations of BRAF Tan Y; Zhong J; Zheng T; Fu Y; Liu M; Wang G Pediatr Radiol; 2024 Jun; 54(7):1128-1136. PubMed ID: 38771344 [TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation. Han Y; Hou L; Zhao B; Gao L; Li S Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548 [TBL] [Abstract][Full Text] [Related]
29. Coexistence of Rusinek D; Pfeifer A; Krajewska J; Oczko-Wojciechowska M; Handkiewicz-Junak D; Pawlaczek A; Zebracka-Gala J; Kowalska M; Cyplinska R; Zembala-Nozynska E; Chekan M; Chmielik E; Kropinska A; Lamch R; Jurecka-Lubieniecka B; Jarzab B; Czarniecka A Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200646 [No Abstract] [Full Text] [Related]
31. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Kim KH; Suh KS; Kang DW; Kang DY Pathol Int; 2005 Sep; 55(9):540-5. PubMed ID: 16143028 [TBL] [Abstract][Full Text] [Related]
32. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis. Chen S; Niu C; Peng Q; Tang K Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065 [TBL] [Abstract][Full Text] [Related]
33. BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population. Cong R; Ouyang H; Zhou D; Li X; Xia F World J Surg Oncol; 2024 Sep; 22(1):259. PubMed ID: 39342349 [TBL] [Abstract][Full Text] [Related]
34. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis. Kim WW; Ha TK; Bae SK J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976 [TBL] [Abstract][Full Text] [Related]
35. The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant Perampalam S; Wu K; Gild M; Tacon L; Bullock M; Clifton-Bligh R Thyroid; 2024 Sep; 34(9):1082-1093. PubMed ID: 38940753 [No Abstract] [Full Text] [Related]
36. Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis. Li P; Liu Y; Wei T; Wang X; Zhu J; Yang R; Gong Y; Zhao W J Clin Endocrinol Metab; 2024 Mar; 109(4):944-954. PubMed ID: 37967234 [TBL] [Abstract][Full Text] [Related]
37. Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis. Molnár C; Molnár S; Bedekovics J; Mokánszki A; Győry F; Nagy E; Méhes G Pathol Oncol Res; 2019 Jul; 25(3):1191-1197. PubMed ID: 30666518 [TBL] [Abstract][Full Text] [Related]
38. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma. Park AY; Son EJ; Kim JA; Youk JH; Park YJ; Park CS; Chang HS PLoS One; 2014; 9(10):e110868. PubMed ID: 25337709 [TBL] [Abstract][Full Text] [Related]
39. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Kang DY; Kim KH; Kim JM; Kim SH; Kim JY; Baik HW; Kim YS Thyroid; 2007 Nov; 17(11):1031-8. PubMed ID: 17900235 [TBL] [Abstract][Full Text] [Related]
40. Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF Wang YG; Xu FJ; Agyekum EA; Xiang H; Wang YD; Zhang J; Sun H; Zhang GL; Bo XS; Lv WZ; Wang X; Hu SD; Qian XQ Front Endocrinol (Lausanne); 2022; 13():872153. PubMed ID: 35527993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]